Loading…

Antibacterial and Antibiofilm Activity of Endophytic Alternaria sp. Isolated from Eremophila longifolia

The threat to public health resulting from the emergence of antimicrobial resistance (AMR) is ever rising. One of the major bacterial pathogens at the forefront of this problem is methicillin-resistant Staphylococcus aureus, or MRSA, for which there is a great need to find alternative treatments. On...

Full description

Saved in:
Bibliographic Details
Published in:Antibiotics (Basel) 2023-09, Vol.12 (9), p.1459
Main Authors: Caruso, Daniel J., Palombo, Enzo A., Moulton, Simon E., Duggan, Peter J., Zaferanloo, Bita
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c477t-6b4f078e5e9cb9041c1d85888d5edcc4b089faec56f89ac07f30bbb7a76ca3173
cites cdi_FETCH-LOGICAL-c477t-6b4f078e5e9cb9041c1d85888d5edcc4b089faec56f89ac07f30bbb7a76ca3173
container_end_page
container_issue 9
container_start_page 1459
container_title Antibiotics (Basel)
container_volume 12
creator Caruso, Daniel J.
Palombo, Enzo A.
Moulton, Simon E.
Duggan, Peter J.
Zaferanloo, Bita
description The threat to public health resulting from the emergence of antimicrobial resistance (AMR) is ever rising. One of the major bacterial pathogens at the forefront of this problem is methicillin-resistant Staphylococcus aureus, or MRSA, for which there is a great need to find alternative treatments. One of the most promising alternatives is endophytic fungi, which were shown to produce a vast array of bioactive compounds, including many novel antibacterial compounds. In this study, two endophytic Alternaria sp., EL 24 and EL 35, were identified from the leaves of Eremophila longifolia. Ethyl acetate (EtOAc) extracts of their culture filtrates were found to inhibit both methicillin-sensitive S. aureus ATCC 25923 and MRSA strains M173525 and M180920. The activity of each extract was shown to be greatly affected by the growth medium, with considerable reductions in minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) observed when tested in tryptic soy broth with glucose (TSBG) compared with Mueller–Hinton broth (MHB). Both extracts displayed significant (p ≤ 0.05) antibiofilm activity against all three S. aureus strains, the greatest of which was that of EL 35, which reduced biofilm formation by M180920 by 72%, while that of EL 24 resulted in a 57% reduction against ATCC 25923. Both extracts also disrupted established biofilms, of which the most effective was EL 35, which reduced the M180920 biofilm by 64%, while EL 24 also performed best against M180920, reducing biofilm by 54%. Gas chromatography–mass spectrometry (GC-MS) analysis of the EL 24 EtOAc extract revealed five known compounds. This study highlights the promise of endophytic fungi from Australian plants as a potential source of substances effective against important bacterial pathogens. Further understanding of the responsible compounds and their mechanisms could lead to the development of treatments effective against MRSA, as well as novel biofilm-resistant biomedical materials, contributing towards reducing the burden of AMR.
doi_str_mv 10.3390/antibiotics12091459
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c448e4e60e1b4e56974470ca8a5560e5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c448e4e60e1b4e56974470ca8a5560e5</doaj_id><sourcerecordid>2869211834</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-6b4f078e5e9cb9041c1d85888d5edcc4b089faec56f89ac07f30bbb7a76ca3173</originalsourceid><addsrcrecordid>eNptkkFrHCEUgKW00LDJL-hF6KWXTXXUUU9lCNt0IZBLe5Y3jm5cnHGrbmD_fd1uKE2pF-X5-b3n4yH0gZJbxjT5DEsNY0g12EI7oikX-g266ojU656p7u1f5_foppQ9aUtTpoi6Qrvh_BpsdTlAxLBMeLj4fIgzHmwNz6GecPJ4s0zp8HRqefAQG79Ae4LL4RZvS4pQ3YR9TjPeZDc3METAMS274FMMcI3eeYjF3bzsK_Tj6-b73bf1w-P99m54WFsuZV33I_dEKiectqMmnFo6KaGUmoSbrOUjUdqDs6L3SoMl0jMyjqME2VtgVLIV2l68U4K9OeQwQz6ZBMH8DqS8M5DbF6IzlnPluOuJoyN3oteSc0ksKBCiBUVzfbm4DsdxbundUjPEV9LXN0t4Mrv0bCgRnVCtxSv06cWQ08-jK9XMoVgXIywuHYvplCSUayLPhX_8B92nY-txPFO97ihVjDeKXSibUynZ-T_VUGLO02D-Mw3sFzQ1rTs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2869211834</pqid></control><display><type>article</type><title>Antibacterial and Antibiofilm Activity of Endophytic Alternaria sp. Isolated from Eremophila longifolia</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><creator>Caruso, Daniel J. ; Palombo, Enzo A. ; Moulton, Simon E. ; Duggan, Peter J. ; Zaferanloo, Bita</creator><creatorcontrib>Caruso, Daniel J. ; Palombo, Enzo A. ; Moulton, Simon E. ; Duggan, Peter J. ; Zaferanloo, Bita</creatorcontrib><description>The threat to public health resulting from the emergence of antimicrobial resistance (AMR) is ever rising. One of the major bacterial pathogens at the forefront of this problem is methicillin-resistant Staphylococcus aureus, or MRSA, for which there is a great need to find alternative treatments. One of the most promising alternatives is endophytic fungi, which were shown to produce a vast array of bioactive compounds, including many novel antibacterial compounds. In this study, two endophytic Alternaria sp., EL 24 and EL 35, were identified from the leaves of Eremophila longifolia. Ethyl acetate (EtOAc) extracts of their culture filtrates were found to inhibit both methicillin-sensitive S. aureus ATCC 25923 and MRSA strains M173525 and M180920. The activity of each extract was shown to be greatly affected by the growth medium, with considerable reductions in minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) observed when tested in tryptic soy broth with glucose (TSBG) compared with Mueller–Hinton broth (MHB). Both extracts displayed significant (p ≤ 0.05) antibiofilm activity against all three S. aureus strains, the greatest of which was that of EL 35, which reduced biofilm formation by M180920 by 72%, while that of EL 24 resulted in a 57% reduction against ATCC 25923. Both extracts also disrupted established biofilms, of which the most effective was EL 35, which reduced the M180920 biofilm by 64%, while EL 24 also performed best against M180920, reducing biofilm by 54%. Gas chromatography–mass spectrometry (GC-MS) analysis of the EL 24 EtOAc extract revealed five known compounds. This study highlights the promise of endophytic fungi from Australian plants as a potential source of substances effective against important bacterial pathogens. Further understanding of the responsible compounds and their mechanisms could lead to the development of treatments effective against MRSA, as well as novel biofilm-resistant biomedical materials, contributing towards reducing the burden of AMR.</description><identifier>ISSN: 2079-6382</identifier><identifier>EISSN: 2079-6382</identifier><identifier>DOI: 10.3390/antibiotics12091459</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Acetic acid ; Alternaria ; Antibacterial materials ; antibiofilm ; Antibiotics ; antimicrobial ; Antimicrobial agents ; Antimicrobial resistance ; Bioactive compounds ; Biofilms ; Biomedical materials ; Cancer ; Drug resistance ; Endophytes ; Eremophila ; Ethyl acetate ; Fungi ; Gas chromatography ; Health risks ; Mass spectrometry ; Mass spectroscopy ; Methicillin ; MRSA ; natural products ; Nosocomial infections ; Pathogens ; Public health ; Staphylococcus aureus ; Staphylococcus infections ; Strains (organisms)</subject><ispartof>Antibiotics (Basel), 2023-09, Vol.12 (9), p.1459</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-6b4f078e5e9cb9041c1d85888d5edcc4b089faec56f89ac07f30bbb7a76ca3173</citedby><cites>FETCH-LOGICAL-c477t-6b4f078e5e9cb9041c1d85888d5edcc4b089faec56f89ac07f30bbb7a76ca3173</cites><orcidid>0009-0005-6580-2973 ; 0000-0002-8320-3852 ; 0000-0001-5889-1393 ; 0000-0003-3378-0229</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2869211834/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2869211834?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids></links><search><creatorcontrib>Caruso, Daniel J.</creatorcontrib><creatorcontrib>Palombo, Enzo A.</creatorcontrib><creatorcontrib>Moulton, Simon E.</creatorcontrib><creatorcontrib>Duggan, Peter J.</creatorcontrib><creatorcontrib>Zaferanloo, Bita</creatorcontrib><title>Antibacterial and Antibiofilm Activity of Endophytic Alternaria sp. Isolated from Eremophila longifolia</title><title>Antibiotics (Basel)</title><description>The threat to public health resulting from the emergence of antimicrobial resistance (AMR) is ever rising. One of the major bacterial pathogens at the forefront of this problem is methicillin-resistant Staphylococcus aureus, or MRSA, for which there is a great need to find alternative treatments. One of the most promising alternatives is endophytic fungi, which were shown to produce a vast array of bioactive compounds, including many novel antibacterial compounds. In this study, two endophytic Alternaria sp., EL 24 and EL 35, were identified from the leaves of Eremophila longifolia. Ethyl acetate (EtOAc) extracts of their culture filtrates were found to inhibit both methicillin-sensitive S. aureus ATCC 25923 and MRSA strains M173525 and M180920. The activity of each extract was shown to be greatly affected by the growth medium, with considerable reductions in minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) observed when tested in tryptic soy broth with glucose (TSBG) compared with Mueller–Hinton broth (MHB). Both extracts displayed significant (p ≤ 0.05) antibiofilm activity against all three S. aureus strains, the greatest of which was that of EL 35, which reduced biofilm formation by M180920 by 72%, while that of EL 24 resulted in a 57% reduction against ATCC 25923. Both extracts also disrupted established biofilms, of which the most effective was EL 35, which reduced the M180920 biofilm by 64%, while EL 24 also performed best against M180920, reducing biofilm by 54%. Gas chromatography–mass spectrometry (GC-MS) analysis of the EL 24 EtOAc extract revealed five known compounds. This study highlights the promise of endophytic fungi from Australian plants as a potential source of substances effective against important bacterial pathogens. Further understanding of the responsible compounds and their mechanisms could lead to the development of treatments effective against MRSA, as well as novel biofilm-resistant biomedical materials, contributing towards reducing the burden of AMR.</description><subject>Acetic acid</subject><subject>Alternaria</subject><subject>Antibacterial materials</subject><subject>antibiofilm</subject><subject>Antibiotics</subject><subject>antimicrobial</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial resistance</subject><subject>Bioactive compounds</subject><subject>Biofilms</subject><subject>Biomedical materials</subject><subject>Cancer</subject><subject>Drug resistance</subject><subject>Endophytes</subject><subject>Eremophila</subject><subject>Ethyl acetate</subject><subject>Fungi</subject><subject>Gas chromatography</subject><subject>Health risks</subject><subject>Mass spectrometry</subject><subject>Mass spectroscopy</subject><subject>Methicillin</subject><subject>MRSA</subject><subject>natural products</subject><subject>Nosocomial infections</subject><subject>Pathogens</subject><subject>Public health</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus infections</subject><subject>Strains (organisms)</subject><issn>2079-6382</issn><issn>2079-6382</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkkFrHCEUgKW00LDJL-hF6KWXTXXUUU9lCNt0IZBLe5Y3jm5cnHGrbmD_fd1uKE2pF-X5-b3n4yH0gZJbxjT5DEsNY0g12EI7oikX-g266ojU656p7u1f5_foppQ9aUtTpoi6Qrvh_BpsdTlAxLBMeLj4fIgzHmwNz6GecPJ4s0zp8HRqefAQG79Ae4LL4RZvS4pQ3YR9TjPeZDc3METAMS274FMMcI3eeYjF3bzsK_Tj6-b73bf1w-P99m54WFsuZV33I_dEKiectqMmnFo6KaGUmoSbrOUjUdqDs6L3SoMl0jMyjqME2VtgVLIV2l68U4K9OeQwQz6ZBMH8DqS8M5DbF6IzlnPluOuJoyN3oteSc0ksKBCiBUVzfbm4DsdxbundUjPEV9LXN0t4Mrv0bCgRnVCtxSv06cWQ08-jK9XMoVgXIywuHYvplCSUayLPhX_8B92nY-txPFO97ihVjDeKXSibUynZ-T_VUGLO02D-Mw3sFzQ1rTs</recordid><startdate>20230919</startdate><enddate>20230919</enddate><creator>Caruso, Daniel J.</creator><creator>Palombo, Enzo A.</creator><creator>Moulton, Simon E.</creator><creator>Duggan, Peter J.</creator><creator>Zaferanloo, Bita</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0005-6580-2973</orcidid><orcidid>https://orcid.org/0000-0002-8320-3852</orcidid><orcidid>https://orcid.org/0000-0001-5889-1393</orcidid><orcidid>https://orcid.org/0000-0003-3378-0229</orcidid></search><sort><creationdate>20230919</creationdate><title>Antibacterial and Antibiofilm Activity of Endophytic Alternaria sp. Isolated from Eremophila longifolia</title><author>Caruso, Daniel J. ; Palombo, Enzo A. ; Moulton, Simon E. ; Duggan, Peter J. ; Zaferanloo, Bita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-6b4f078e5e9cb9041c1d85888d5edcc4b089faec56f89ac07f30bbb7a76ca3173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Acetic acid</topic><topic>Alternaria</topic><topic>Antibacterial materials</topic><topic>antibiofilm</topic><topic>Antibiotics</topic><topic>antimicrobial</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial resistance</topic><topic>Bioactive compounds</topic><topic>Biofilms</topic><topic>Biomedical materials</topic><topic>Cancer</topic><topic>Drug resistance</topic><topic>Endophytes</topic><topic>Eremophila</topic><topic>Ethyl acetate</topic><topic>Fungi</topic><topic>Gas chromatography</topic><topic>Health risks</topic><topic>Mass spectrometry</topic><topic>Mass spectroscopy</topic><topic>Methicillin</topic><topic>MRSA</topic><topic>natural products</topic><topic>Nosocomial infections</topic><topic>Pathogens</topic><topic>Public health</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus infections</topic><topic>Strains (organisms)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caruso, Daniel J.</creatorcontrib><creatorcontrib>Palombo, Enzo A.</creatorcontrib><creatorcontrib>Moulton, Simon E.</creatorcontrib><creatorcontrib>Duggan, Peter J.</creatorcontrib><creatorcontrib>Zaferanloo, Bita</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Antibiotics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caruso, Daniel J.</au><au>Palombo, Enzo A.</au><au>Moulton, Simon E.</au><au>Duggan, Peter J.</au><au>Zaferanloo, Bita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibacterial and Antibiofilm Activity of Endophytic Alternaria sp. Isolated from Eremophila longifolia</atitle><jtitle>Antibiotics (Basel)</jtitle><date>2023-09-19</date><risdate>2023</risdate><volume>12</volume><issue>9</issue><spage>1459</spage><pages>1459-</pages><issn>2079-6382</issn><eissn>2079-6382</eissn><abstract>The threat to public health resulting from the emergence of antimicrobial resistance (AMR) is ever rising. One of the major bacterial pathogens at the forefront of this problem is methicillin-resistant Staphylococcus aureus, or MRSA, for which there is a great need to find alternative treatments. One of the most promising alternatives is endophytic fungi, which were shown to produce a vast array of bioactive compounds, including many novel antibacterial compounds. In this study, two endophytic Alternaria sp., EL 24 and EL 35, were identified from the leaves of Eremophila longifolia. Ethyl acetate (EtOAc) extracts of their culture filtrates were found to inhibit both methicillin-sensitive S. aureus ATCC 25923 and MRSA strains M173525 and M180920. The activity of each extract was shown to be greatly affected by the growth medium, with considerable reductions in minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) observed when tested in tryptic soy broth with glucose (TSBG) compared with Mueller–Hinton broth (MHB). Both extracts displayed significant (p ≤ 0.05) antibiofilm activity against all three S. aureus strains, the greatest of which was that of EL 35, which reduced biofilm formation by M180920 by 72%, while that of EL 24 resulted in a 57% reduction against ATCC 25923. Both extracts also disrupted established biofilms, of which the most effective was EL 35, which reduced the M180920 biofilm by 64%, while EL 24 also performed best against M180920, reducing biofilm by 54%. Gas chromatography–mass spectrometry (GC-MS) analysis of the EL 24 EtOAc extract revealed five known compounds. This study highlights the promise of endophytic fungi from Australian plants as a potential source of substances effective against important bacterial pathogens. Further understanding of the responsible compounds and their mechanisms could lead to the development of treatments effective against MRSA, as well as novel biofilm-resistant biomedical materials, contributing towards reducing the burden of AMR.</abstract><cop>Basel</cop><pub>MDPI AG</pub><doi>10.3390/antibiotics12091459</doi><orcidid>https://orcid.org/0009-0005-6580-2973</orcidid><orcidid>https://orcid.org/0000-0002-8320-3852</orcidid><orcidid>https://orcid.org/0000-0001-5889-1393</orcidid><orcidid>https://orcid.org/0000-0003-3378-0229</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2079-6382
ispartof Antibiotics (Basel), 2023-09, Vol.12 (9), p.1459
issn 2079-6382
2079-6382
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c448e4e60e1b4e56974470ca8a5560e5
source ProQuest - Publicly Available Content Database; PubMed Central
subjects Acetic acid
Alternaria
Antibacterial materials
antibiofilm
Antibiotics
antimicrobial
Antimicrobial agents
Antimicrobial resistance
Bioactive compounds
Biofilms
Biomedical materials
Cancer
Drug resistance
Endophytes
Eremophila
Ethyl acetate
Fungi
Gas chromatography
Health risks
Mass spectrometry
Mass spectroscopy
Methicillin
MRSA
natural products
Nosocomial infections
Pathogens
Public health
Staphylococcus aureus
Staphylococcus infections
Strains (organisms)
title Antibacterial and Antibiofilm Activity of Endophytic Alternaria sp. Isolated from Eremophila longifolia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T07%3A59%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibacterial%20and%20Antibiofilm%20Activity%20of%20Endophytic%20Alternaria%20sp.%20Isolated%20from%20Eremophila%20longifolia&rft.jtitle=Antibiotics%20(Basel)&rft.au=Caruso,%20Daniel%20J.&rft.date=2023-09-19&rft.volume=12&rft.issue=9&rft.spage=1459&rft.pages=1459-&rft.issn=2079-6382&rft.eissn=2079-6382&rft_id=info:doi/10.3390/antibiotics12091459&rft_dat=%3Cproquest_doaj_%3E2869211834%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-6b4f078e5e9cb9041c1d85888d5edcc4b089faec56f89ac07f30bbb7a76ca3173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2869211834&rft_id=info:pmid/&rfr_iscdi=true